GYNECOLOGIC ONCOLOGY GROUP

妇科肿瘤组

• 批准号: 3556205
• 负责人: JONATHAN S BEREK
• 金额: $ 0.95万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 1978
• 资助国家: 美国
• 起止时间: 1978-06-01 至 1989-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/3556205
• 关键词: cervix neoplasms; cooperative study; cyclophosphamide; fluorouracil; human subject; human therapy evaluation; medical outreach /case finding; melphalan; neoplasm /cancer chemotherapy; neoplasm /cancer radiation therapy; neoplasm /cancer relapse /recurrence; ovary; urea

The objectives of the UCLA Gynecologic Oncology Group participation may be summarized as follows: a) to continue to accession a significant number of cases for pilot sutides and randomized controlled clinical trials b) to assist in the formulation of Gynecologic Oncology Group Policy c) to assist in the dissemination and publication of Gynecologic Oncology Group findings

加州大学洛杉矶分校妇科肿瘤组参与的目的可能是 摘要如下： a）继续接收大量的试点个案 随机对照临床试验 B）协助制定妇科肿瘤组政策 c）协助传播和出版《妇科肿瘤学》 小组调查结果

项目成果

Treatment of vulvar intraepithelial neoplasia (VIN) with local bleomycin.

用局部博来霉素治疗外阴上皮内瘤变（VIN）。

• 发表时间: 1980
• 期刊: Cancer clinical trials
• 作者: Roberts,JA;Watring,WG;Lagasse,LD
• 通讯作者: Lagasse,LD

A phase II trial of leuprolide acetate in patients with advanced epithelial ovarian carcinoma. A Gynecologic Oncology Group study.

醋酸亮丙瑞林治疗晚期上皮性卵巢癌患者的 II 期试验。

• DOI: 10.1097/00000421-199204000-00006
• 发表时间: 1992
• 期刊: American journal of clinical oncology
• 作者: Miller,DS;Brady,MF;Barrett,RJ
• 通讯作者: Barrett,RJ

A phase II trial of Didemnin B (NSC #335319) in patients with previously treated epithelial ovarian cancer. A Gynecologic Oncology Group Study.

Didemnin B 的 II 期试验（NSC

• DOI: 10.1097/00000421-199302000-00012
• 发表时间: 1993
• 期刊: American journal of clinical oncology
• 作者: Malfetano,JH;Blessing,JA;Jacobs,AJ
• 通讯作者: Jacobs,AJ

Multidrug Treatment of Advanced and Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study

晚期和复发性子宫内膜癌的多药治疗：一项妇科肿瘤学小组研究

• 发表时间: 1984
• 期刊: Obstetrics and Gynecology
• 影响因子: 7.2
• 作者: C. Cohen;H. Bruckner;M. Deppe;J. Blessing;H. Homesley;J. Lee;W. Watring
• 通讯作者: W. Watring

Phase II study of N-methylformamide (N-MF) (NSC 3051) in patients with advanced epithelial ovarian cancer. A Gynecologic Oncology Group study.

N-甲基甲酰胺 (N-MF) (NSC 3051) 在晚期上皮性卵巢癌患者中的 II 期研究。

• DOI: 10.1007/bf00177257
• 发表时间: 1990
• 期刊: Investigational new drugs
• 影响因子: 3.4
• 作者: McGuire3rd,WP;Blessing,JA;Berek,JS;Munoz,A
• 通讯作者: Munoz,A